BGLCBioNexus Gene Lab Corp Common stock
1.590USDMkt Cap: 4.66M $P/E: —3d ago
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malay…
Industry Peers
Specialty ChemicalsKey Statistics
Company
Market Cap4.66M $
Enterprise Value1.47M $
Revenue (TTM)3.13M $
Gross Profit1.09M $
Net Income (TTM)-2.98M $
Revenue/Share1.443 USD
Last Price1.590 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees19
CountryUS
SectorHealthcare
IndustrySpecialty Chemicals
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.56
EV/Revenue0.47
P/S1.49
P/B0.49
EPS (TTM)-1.26
EPS (Forward)—
52W Range
1.5900% of range1.700
52W High1.700 USD
52W Low1.590 USD
Profitability
Gross Margin14.62%
Oper. Margin-398.69%
EBITDA Margin-84.44%
Profit Margin-40.20%
ROE-34.64%
ROA-32.26%
Growth
Revenue Growth-96.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.84M $
CapEx (TTM)36.97K $
FCF Margin2.18%
FCF Yield1.46%
Net Debt-3.20M $
Net Debt/EBITDA1.21
Balance Sheet
Debt/Equity0.02
Current Ratio6.08
Quick Ratio4.56
Book Value/Sh3.218 USD
Cash/Share1.200 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateApr 7, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.93M
Float1.03M
Insiders44.72%
Institutions0.49%
Short Interest
Short Ratio0.7d
Short % Float0.32%
Short % Out.0.27%
Shares Short6.42K
Short (prev mo.)14.64K
Technical
SMA 501.789 (-11.1%)
SMA 2002.698 (-41.1%)
Beta2.19
S&P 52W Chg19.18%
Avg Vol (30d)985
Avg Vol (10d)12.87K
Technical Indicators
RSI (14)48.6
MACD-0.0359
MACD Signal-0.0625
MACD Hist.+0.0266
BB Upper1.723 USD
BB Middle1.508 USD
BB Lower1.294 USD
BB Width28.40%
ATR (14)0.1187 USD
Vol Ratio (20d)0.05x